In the Litigation Daily article by Julie Triedman, "Supreme Court of Canada Rules for GlaxoSmithKline in Transfer-Pricing Case", Claire Kennedy comments on the Supreme Court decision that the Canadian government had to take into account more than just the narrow market price of a product when assessing whether GlaxoSmithKline's transfer pricing was reasonable.
In The News
Claire Kennedy in the Litigation Daily on GlaxoSmithKline Transfer-Pricing Case
December 14, 2012
Republishing Requests
For permission to republish this or any other publication, contact Amrita Kochhar at kochhara@bennettjones.com.
For informational purposes only
This publication provides an overview of legal trends and updates for informational purposes only. For personalized legal advice, please contact the authors.
Latest Insights
See All Insights
Blog
Jane C. Helmstadter & Mykala Way
One Method, Many Taxes: Lease Interpretation and Realty Tax Allocation in 100 Bloor Street West v. Barry’s Bootcamp
October 29, 2025
Blog
Michelle F. Yung & Vanessa Kiraly
When Assumptions Break Leases: The Need for Clear Terms
October 28, 2025
Blog
& 2 more
OSB Issues New Guidance: What Licensed Insolvency Trustees Must Know about AI Tools
October 28, 2025